Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Insulin Degludec and Insulin Aspart) Instrument 2024 (Cth)

Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Insulin Degludec and Insulin Aspart) Instrument 2024

I, Nicholas Henderson, as delegate of the Minister for Health and Aged Care, make the following instrument.

Dated 23 September 2024

Nicholas Henderson First Assistant Secretary Medicines Regulation Division Health Products Regulation Group Department of Health and Aged Care

Contents 1 Name 2 Commencement 3 Authority 4 Definitions 5 Declaration of serious scarcity 6 Substitution of scarce medicine by pharmacists 7 Period instrument in force 8 Repeals Schedule 1—Scarce medicine, substitutable medicine, dose unit equivalence and specific permitted circumstances Schedule 2—General permitted circumstances

1 Name This instrument is the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Insulin Degludec and Insulin Aspart) Instrument 2024.

2 Commencement (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this instrument 27 September 2024. 27 September 2024

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority This instrument is made under section 30EK of the Therapeutic Goods Act 1989.